ESMO 20th World Congress on Gastrointestinal Cancer has ended

Create Your Own Event

ESMO 20th World Congress on Gastrointestinal Cancer

16:40 PDT

Is adjuvant or neo-adjuvant treatment for resectable pancreatic cancer the way to go? Auditorium A, Level 0Jordan D. Berlin • Pascal Hammel

17:00 PDT

Adjuvant treatment of pancreatic cancer Auditorium A, Level 0Thierry Conroy • Jean-Luc VanLaethem

08:40 PDT

What to use and to improve the evaluation of responses Auditorium A, Level 0Christoph Deroose • Raquel Perez-Lopez

09:31 PDT

Management of squamous cell cancer for the esophagus Auditorium A, Level 0David H. Ilson • Florian Lordick

09:55 PDT

Locally advanced GE junction cancer Auditorium A, Level 0David Cunningham • David H. Ilson

11:35 PDT

Debate: This house believes multiparametric MRI is the holy grail for organ preservation in rectal cancer Auditorium A, Level 0Regina G.H. Beets-Tan • Karin Haustermans

11:55 PDT

Rectal cancer after neoadjuvant therapy with complete clinical response Auditorium A, Level 0Rodrigo Perez • Eric Rullier

16:05 PDT

Is broad NGS testing useful in patients with metastatic colorectal cancer? Auditorium A, Level 0Rodrigo Dienstmann • Howard Hochster

18:21 PDT

What do the new evolutions in GI cancer mean for my practice? Auditorium A, Level 0Jorge Gallardo • Brigetta Ma • Ali Shamseddine

08:31 PDT

How can we deal with the explosion of new treatments Auditorium A, Level 0Jorge Camarero • Jean-Yves Douillard • Steven Lemery